Final Immediately Dangerous to Life or Health (IDLH) Value Profiles, 50429 [2017-23665]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices
50429
Dated: October 25, 2017.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–23669 Filed 10–30–17; 8:45 am]
[Docket No. FDA–2017–N–5897]
References
asabaliauskas on DSKBBXCHB2PROD with NOTICES
(6) How can CDC support state and
local health departments, traditional
healthcare providers, not for profit
health institutions, and professional
healthcare partner organizations to
ensure that evidence-based tobacco
cessation interventions are integrated
into primary and behavioral health care
settings on a consistent and sustainable
basis?
(7) How can the public health sector
most effectively maximize the impact of
public and private insurance coverage of
cessation treatments as part of efforts to
ensure that all tobacco users have
barrier-free access to these treatments?
Final Immediately Dangerous to Life or
Health (IDLH) Value Profiles
1. U.S. Department of Health and Human
Services. The Health Consequences of
Smoking—50 Years of Progress: A Report
of the Surgeon General. Atlanta: U.S.
Department of Health and Human
Services, Centers for Disease Control and
Prevention, National Center for Chronic
Disease Prevention and Health
Promotion, Office on Smoking and
Health, 2014.
2. Xu X, Bishop EE, Kennedy SM, Simpson
SA, Pechacek TF. Annual Healthcare
Spending Attributable to Cigarette
Smoking: An Update. American Journal
of Preventive Medicine 2014;48(3):326–
33.
3. Babb S, Malarcher A, Schauer G, Asman
K, Jamal A. Quitting Smoking Among
Adults—United States, 2000–2015.
MMWR Morb Mortal Wkly Rep
2017;65:1457–1464.
4. Siu AL; US Preventive Services Task
Force. Behavioral and pharmacotherapy
interventions for tobacco smoking
cessation in adults, including pregnant
women: U.S. Preventive Services Task
Force recommendation statement. Ann
Intern Med 2015;163:622–34.
´
5. Fiore MC, Jaen CR, Baker TB, et al.
Treating Tobacco Use and Dependence:
2008 Update—Clinical Practice
Guidelines. Rockville (MD): U.S.
Department of Health and Human
Services, Public Health Service, Agency
for Healthcare Research and Quality,
2008.
6. Jamal A, King BA, Neff LJ, Whitmill J,
Babb SD, Graffunder CM. Current
Cigarette Smoking Among Adults—
United States, 2005–2015. MMWR Morb
Mortal Wkly Rep 2016;65:1205–1211.
7. Institute of Medicine. Ending the Tobacco
Problem: A Blueprint for the Nation.
Washington: The National Academies
Press, 2007.
8. Jha P, Ramasundarahettige C, Landsman V,
Rostron B, Thun M, Anderson RN,
McAfee T, Peto R. 21st-century hazards
of smoking and benefits of cessation in
the United States. New England Journal
of Medicine 2013;368(4):341–50.
VerDate Sep<11>2014
17:37 Oct 30, 2017
Jkt 244001
Food and Drug Administration
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Packaging, Storage, and Disposal
Options To Enhance Opioid Safety—
Exploring the Path Forward; Public
Workshop; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public workshop;
request for comments.
ACTION:
[CDC–2017–0048; Docket Number NIOSH–
156–C]
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
AGENCY:
ACTION:
Notice of availability.
NIOSH announces the
availability of the following four
Immediately Dangerous to Life or Health
(IDLH) Value Profile documents:
Acetonitrile [CAS No. 75–05–8],
Chloroacetonitrile [CAS No. 107–14–2],
Methacrylonitrile [CAS No. 126–98–7],
and Nitrogen dioxide [CAS No. 10102–
44–0].
SUMMARY:
The final IDLH Value Profile
documents were published on
September 29, 2017.
DATES:
These documents may be
obtained at the following link: https://
www.cdc.gov/niosh/idlh/default.html.
ADDRESSES:
R.
Todd Niemeier, MS, CIH, NIOSH,
Education and Information Division
(EID), Robert A. Taft Laboratories, 1090
Tusculum Ave., MS–C32, Cincinnati,
OH 45226, phone 513/533–8166 (not a
toll-free number), email: rbn4@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
On May 5,
2017, NIOSH published a request for
public review in the Federal Register
[82 FR 21239] on IDLH Value profiles.
We did not receive public comments,
but did receive peer and stakeholder
comments. These comments received
were reviewed and addressed where
appropriate.
SUPPLEMENTARY INFORMATION:
Frank Hearl,
Chief of Staff, National Institute for
Occupational Safety and Health, Centers for
Disease Control and Prevention.
[FR Doc. 2017–23665 Filed 10–30–17; 8:45 am]
BILLING CODE 4163–19–P
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing the following public
workshop entitled ‘‘Packaging, Storage,
and Disposal Options To Enhance
Opioid Safety—Exploring the Path
Forward.’’ The purpose of this 2-day
public workshop is to host a scientific
discussion with experts and seek input
from interested stakeholders regarding
the role of packaging, storage, and
disposal options within the larger
landscape of activities aimed at
addressing abuse, misuse, or
inappropriate access of prescription
opioid drug products (opioids); guiding
principles and considerations for the
design of packaging, storage, and
disposal options for opioids; integrating
packaging, storage, and disposal options
into existing health care and pharmacy
systems, including both open and
closed health care systems (e.g., a closed
system such as the U.S. Department of
Veterans Affairs); data needs and how to
address challenges in assessing the
impact of packaging, storage, and
disposal options in both the premarket
and postmarket settings; and ways in
which FDA could encourage the
development and assessment of
packaging, storage, and disposal options
for opioids that have the potential to
enhance opioid safety.
DATES: The public workshop will be
held on December 11 and 12, 2017, from
8:30 a.m. to 5 p.m. Submit either
electronic or written comments on this
public workshop by February 12, 2018.
See the SUPPLEMENTARY INFORMATION
section for registration date and
information.
SUMMARY:
The public workshop will
be held at the Sheraton Silver Spring
Hotel, 8777 Georgia Ave., Silver Spring,
MD 20910. The hotel’s phone number is
301–589–0800.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
Electronic comments must be submitted
on or before February 12, 2018. The
ADDRESSES:
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 82, Number 209 (Tuesday, October 31, 2017)]
[Notices]
[Page 50429]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23665]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CDC-2017-0048; Docket Number NIOSH-156-C]
Final Immediately Dangerous to Life or Health (IDLH) Value
Profiles
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: NIOSH announces the availability of the following four
Immediately Dangerous to Life or Health (IDLH) Value Profile documents:
Acetonitrile [CAS No. 75-05-8], Chloroacetonitrile [CAS No. 107-14-2],
Methacrylonitrile [CAS No. 126-98-7], and Nitrogen dioxide [CAS No.
10102-44-0].
DATES: The final IDLH Value Profile documents were published on
September 29, 2017.
ADDRESSES: These documents may be obtained at the following link:
https://www.cdc.gov/niosh/idlh/default.html.
FOR FURTHER INFORMATION CONTACT: R. Todd Niemeier, MS, CIH, NIOSH,
Education and Information Division (EID), Robert A. Taft Laboratories,
1090 Tusculum Ave., MS-C32, Cincinnati, OH 45226, phone 513/533-8166
(not a toll-free number), email: [email protected].
SUPPLEMENTARY INFORMATION: On May 5, 2017, NIOSH published a request
for public review in the Federal Register [82 FR 21239] on IDLH Value
profiles. We did not receive public comments, but did receive peer and
stakeholder comments. These comments received were reviewed and
addressed where appropriate.
Frank Hearl,
Chief of Staff, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2017-23665 Filed 10-30-17; 8:45 am]
BILLING CODE 4163-19-P
